003120 Stock Chart & Stats
₩20350.00
-₩150.00(-0.73%)
―
--
Day’s Range― - ―
52-Week Range₩17,120.00 - ₩29,300.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)11.43K
Market Cap
₩249.56B
Enterprise ValueN/A
Total Cash (Recent Filing)₩226.14B
Total Debt (Recent Filing)₩139.75M
Price to Earnings (P/E)―
Beta0.22
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-64.18
Shares Outstanding13,300,000
10 Day Avg. Volume14,668
30 Day Avg. Volume11,426
Financial Highlights & Ratios
PEG Ratio-1.41
Price to Book (P/B)0.75
Price to Sales (P/S)4.51
P/FCF Ratio19.15
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
003120 FAQ
What was ILSUNG IS CO., LTD.’s price range in the past 12 months?
ILSUNG IS CO., LTD. lowest stock price was ₩17120.00 and its highest was ₩29300.00 in the past 12 months.
What is ILSUNG IS CO., LTD.’s market cap?
ILSUNG IS CO., LTD.’s market cap is ₩249.56B.
When is ILSUNG IS CO., LTD.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ILSUNG IS CO., LTD.’s earnings last quarter?
ILSUNG IS CO., LTD. released its earnings results on May 15, 2026. The company reported ₩220.229 earnings per share for the quarter, beating the consensus estimate of N/A by ₩220.229.
Is ILSUNG IS CO., LTD. overvalued?
According to Wall Street analysts ILSUNG IS CO., LTD.’s price is currently Undervalued.
Does ILSUNG IS CO., LTD. pay dividends?
ILSUNG IS CO., LTD. does not currently pay dividends.
What is ILSUNG IS CO., LTD.’s EPS estimate?
ILSUNG IS CO., LTD.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ILSUNG IS CO., LTD. have?
ILSUNG IS CO., LTD. has 13,300,000 shares outstanding.
What happened to ILSUNG IS CO., LTD.’s price movement after its last earnings report?
ILSUNG IS CO., LTD. reported an EPS of ₩220.229 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of ILSUNG IS CO., LTD.?
Currently, no hedge funds are holding shares in KR:003120
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ILSUNG IS CO., LTD.
Founded in 1954, Ilsung Pharmaceuticals Co., Ltd. operates as a key pharmaceutical firm in South Korea, headquartered in Seoul. The company specializes in the development and distribution of a comprehensive range of medicinal products. Its extensive portfolio includes antibacterial agents, pain management drugs, muscle relaxants, anticoagulants, various cardiovascular and circulatory system treatments, diagnostic contrast agents, diabetes therapies, gastrointestinal medicines, antiviral compounds, anti-emetic medications, respiratory care solutions, anesthetics, and antipyretics.
YUNGJIN PHARM. CO. LTD
―
Suheung Co. Ltd.
―
Kwang Dong Pharmaceutical Co., Ltd.
―
KOREA UNITED PHARM, INC.
―
JW Holdings Corporation
―